artikel

 

Publicaties

 

 

 

 

 

 


 

    • Managing Patients with von Willebrand Disease Type 1, 2 and 3 with Desmopressin and von Willebrand Factor-Factor VIII Concentrate in Surgical Settings.
      Michiels, J.J. van Vliet, H.H.D.M.; Berneman, Z.; Schroyens, W.; Gadisseur, A. Acta Haematol. 2009;121(2-3):167-76.

 

 

    • Laboratory Diagnosis of von Willebrand Disease Type 1/2E (2A Subtype IIE), Type 1 Vicenza and Mild Type 1 Caused by Mutations in the D3, D4, B1–B3 and C1–C2 Domains of the von Willebrand Factor Gene. Role of von Willebrand Factor Multimers and the von Willebrand Factor Propeptide/Antigen Ratio.
      Gadisseur, A.; Berneman, Z.; Schroyens, W.; Michiels, J.J. Acta Haematol. 2009;121(2-3):128-38.

 

    • Recessive von Willebrand Disease Type 2 Normandy: Variable Expression of Mild Hemophilia and VWD Type 1
      Michiels, J.J. ; Gadisseur, A.; Vangenegten, I.; Schroyens, W.; Berneman, Z. Acta Haematol. 2009;121(2-3):119-27.

 

    • Laboratory and Molecular Characteristics of Recessive von Willebrand Disease Type 2C (2A Subtype IIC) of Variable Severity due to Homozygous or Double Heterozygous Mutations in the D1 and D2 Domains.
      Michiels, J.J.; Gadisseur, A.; van der Planken, M.; Schroyens, W.; Berneman, Z. Acta Haematol. 2009;121(2-3):111-8.

 


 

    • Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1
      Michiels, J.J.; Berneman, Z.; Gadisseur, A.; van der Planken, M.; Schroyens, W., van Vliet, H.H.D.M. Acta Haematol. 2009;121(2-3):85-97.

 

    • Laboratory Diagnosis and Molecular Classification of von Willebrand Disease
      Gadisseur, A. Hermans, C.; Berneman, Z.; Schroyens, W. ,Deckmyn, H.; Michiels, J.J. Acta Haematol. 2009;121(2-3):71-84.

 

    • Proceedings of the European Workshop on von Willebrand Factor and von Willebrand Disease.
      Zwi Berneman , Alain Gadisseur , Wilfried Schroyens, et al. September 28-30, 2007, Antwerp Paperback – 1 Feb 2008.

 

 

    • Intravenous DDAVP and Factor VIII-von Willebrand Factor Concentrate for the Treatment and Prophylaxis of Bleedings in Patients With von Willebrand Disease Type 1, 2 and 3.
      Jan Jacques Michiels, Huub H D M van Vliet, Zwi Berneman, Alain P Gadisseur, Marc Van der Planken, Wilfried Schroyens, Ann van der Velden, Ulrich Budde. Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34.